Aandachtstekortstoornis met hyperactiviteit: ontwikkeling van stimulerende geneesmiddelen voor behandelingsrichtlijnen voor de industri

Aandachtstekortstoornis met hyperactiviteit: ontwikkeling van stimulerende geneesmiddelen voor behandelingsrichtlijnen voor de industri

mei 19, 2020 0 Door admin

Translating…


CBD Olie kan helpen bij ADHD. Lees hoe op MHBioShop.com


Huile de CBD peut aider avec TDAH. Visite HuileCBD.be


 

Docket Number:
FDA-2019-D-0849
Issued by:

Guidance Issuing Office

Center for Drug Evaluation and Research

This guidance is intended to provide general framework recommendations to sponsors  developing stimulant drugs for treatment of attention deficit hyperactivity disorder (ADHD) in  pediatric and adult patients. This guidance does not address development programs for 1nonstimulant drugs.

 ADHD is a common neurobehavioral disorder with onset in childhood. It is characterized by a  pattern of developmentally inappropriate and maladaptive inattentiveness, impulsivity, and  hyperactivity, resulting in impairment in family, social, academic, and occupational functioning.  Stimulant drugs (e.g., methylphenidate, amphetamine) are the most commonly prescribed  medications for treatment of ADHD.


Submit Comments

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document’s docket number: FDA-2019-D-0849.


CBD Olie kan helpen bij ADHD. Lees hoe op MHBioShop.com


Huile de CBD peut aider avec TDAH. Visite HuileCBD.be


 
Lees meer